Pscilly

Reviews of MYCO-003 – Psilocybin-based formulation

No reviews yet. Share the first one.

MYCO-003 – Psilocybin-based formulation by Noveris Health Sciences (formerly Mydecine)

An investigational formulation intended to reduce anxiety potential; an indication was not specified. Its phase is not reported. Investigational; not for sale.

Guides about MYCO-003 – Psilocybin-based formulation

Related news

Glossary: Psilocybin

More from Noveris Health Sciences (formerly Mydecine)